The global revenue for wearables in pharma & biotech experienced significant year-on-year growth, reaching 4,750 Million in 2025 from 3,900 Million in 2024. This upward trajectory is driven by increased adoption of digital health solutions across clinical monitoring and therapeutic interventions. The market is projected to continue its rise, with revenue estimates surpassing 19,200 Million by 2035. Ongoing technological innovations, favorable regulatory landscapes, and growing emphasis on patient-centered care fuel this rapid expansion, securing wearables as a critical component of modern healthcare ecosystems.
Read More - https://bussinessinsights.com/research-report/global-wearables-in-pharma-&-biotech-market
Remote patient monitoring is the leading application, making up 32% of the wearables use in pharma & biotech, followed by disease management at 28%, and clinical trials at 18%. The surging need for real-time health insights, especially among patients managing chronic conditions at home, has propelled the growth of remote monitoring solutions. Disease management applications leverage AI-powered analytics to offer proactive interventions, while clinical trials utilize wearable data for improved study accuracy and participant adherence. Collectively, these applications highlight a strategic shift toward data-centric, patient-focused healthcare.
Request Free Sample- https://bussinessinsights.com/request/healthcare/global-wearables-in-pharma-&-biotech-market
Who are the key players in Global Wearables in Pharma & Biotech Market industry?
The top five players in the Global Wearables in Pharma & Biotech Market are Medtronic, Philips Healthcare, Abbott Laboratories, Fitbit (Google), and BioTelemetry (Philips). These companies drive innovation with advanced wearable solutions for patient monitoring, drug delivery, and clinical trials, establishing leadership worldwide through continuous R&D and strategic partnerships.
What is the Global Wearables in Pharma & Biotech Market growth?
The market has experienced robust growth, with a CAGR exceeding 20% in recent years. A key factor is Abbott’s successful launch of FreeStyle Libre, a continuous glucose monitoring system, which saw strong adoption and showcased the expanding acceptance and clinical value of wearables in pharma and biotech settings.
Which segment accounted for the largest Global Wearables in Pharma & Biotech Market share?
Patient monitoring applications hold the largest market share due to increased demand for real-time health data in clinical trials and chronic disease management. Wearable devices are widely used to monitor heart rate, glucose levels, and drug adherence, improving clinical outcomes and regulatory compliance in pharma and biotech industries.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com